Buying with Sora Consulting Group

Location: City, County, State
Asking Price: $X,XXX,XXX (plus inventory, if applicable)

Inventory Value:
Annual Revenue: $X,XXX,XXX

Gross Profit:
Owner’s Cash Flow / EBITDA: $X,XXX,XXX

Annual Rx Volume:
Pharmacy Type: Retail / LTC / Specialty / Combo

Store Size: Sq ft.
Years in Operation: X Years
Status: Fully Licensed & Operational
Reason for Sale: Owner transitioning to other ventures / retirement / portfolio shift

Lease Remaining: Years

Monthly Rent: $

Property for Sale? Yes / No 

Employees: # Pharmacists / # Techs / # Other

Store Hours: Days & Times

Ownership Structure: Present, Absentee, P.E Backed, Management Will Stay On? 

• Type of Pharmacy: ☐ Retail
  ☐ Long-Term Care (LTC)
  ☐ Specialty / Disease-State Focused
  ☐ Combo / Hybrid
• Services Offered:
  ☐ Retail dispensing
  ☐ Auto-refill programs
  ☐ LTC packaging & delivery
  ☐ Specialty meds
  ☐ Prior authorizations
  ☐ Vaccinations
  ☐ Direct Manufacturer voucher programs 
• Technology & Equipment:
  • Pharmacy system (e.g., BestRx, Pioneer, QS/1, FrameworkLTC)
  • Automation (Parata / TouchPoint / ATP / InspectRx)
  • Additional Systems: 

• Situated in [high-traffic corridor / dense residential / medical hub]
• PBM/Insurance Payor Mix 
• Serves diverse and loyal patient base
• Favorable demographic mix with consistent prescription demand 

Historical Performance

• 2023 Revenue: $X.XM
• 2024 Revenue: $X.XM
• 2025 Revenue: $X.XM (Trailing / Estimated)

Profitability

• Gross Margin: ~X%
• EBITDA Margin: ~X%
• Net Owner Benefit: $X

Financials provided by the seller. Buyers should conduct independent due diligence.

• Fully staffed and operational
• Absentee-owner friendly (if applicable)
• Management transition available
• Staff willing to remain post-sale

• Transaction Type: Asset Sale / Stock Sale
• Seller Financing: Available / On Request / None
• Broker Representation: Yes
• Co-Brokerage: Available upon request
• Buyer Fee: None
• Management Transition: Available

• Expand specialty / disease-state focus
• Add new LTC / SNF / ALF contracts
• Improve payer mix & reimbursement optimization
• Implement enhanced PA workflows
• Extend operating hours
• Add delivery / adherence programs
• Transition to centralized fulfillment (for roll-ups)

All acquisitions are handled with strict confidentiality to protect the pharmacy, its patients, and staff. Detailed financials and operational information are shared only with qualified buyers following execution of a non-disclosure agreement (NDA). Direct contact with the business or employees is strictly prohibited.

All financial information has been provided by the seller and has not been independently verified. Buyers are encouraged to consult with legal, accounting, and industry professionals prior to closing. The broker makes no representations or warranties.